Long-Acting Injectable Cabotegravir Use and Persistence Over 2 Years - Top-Institutions - MDSpire

Long-Acting Injectable Cabotegravir Use and Persistence Over 2 Years

  • By

  • Shi Hao Ernest Koh

  • Wenting Huang

  • Eric W. Hall

  • Jeb Jones

  • Xiao Zang

  • Courtney R. Yarbrough

  • Edwin E. Corbin-Gutierrez

  • Patrick S. Sullivan

  • Aaron J. Siegler

  • June 26, 2026

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    Emory University
    Emory University

    Atlanta, Georgia

    Key Differentiators

    • Infectious Disease

  • #2

    University of Brescia
    University of Brescia

    Brescia, Italy

    Key Differentiators

    • Infectious Disease

  • #3

    Ward 86 clinic
    Ward 86 clinic

    San Francisco, California

    Key Differentiators

    • Infectious Disease

  • #4

    Hospital General Universitario de Elche
    Hospital General Universitario de Elche

    Elche, Spain

    Key Differentiators

    • Infectious Disease

  • #5

    University of Chicago HIV clinic
    University of Chicago HIV clinic

    Chicago, Illinois

    Key Differentiators

    • Infectious Disease

Original Source(s)

Long-Acting Injectable Cabotegravir Use and Persistence Over 2 Years

  • by Shi Hao Ernest Koh, Wenting Huang, Eric W. Hall, Jeb Jones, Xiao Zang, Courtney R. Yarbrough, Edwin E. Corbin-Gutierrez, Patrick S. Sullivan, Aaron J. Siegler

  • June 26, 2026

Related Content

Culture-negative cryptogenic splenic abscess in an immunocompetent host with recurrent misdiagnosis as pleural effusion: a case report with a review of the literature

Biomarker-guided immunomodulation in septic shock: navigating controversies and therapeutic implications for Critical Care

Silver-impregnated occlusive dressing is associated with a lower rate of acute surgical site infection after direct anterior total hip arthroplasty